China External Execution and CRDMO Strategy Lead
AbbVie
China External Execution and CRDMO Strategy Lead
AbbVie
Global biopharmaceutical company developing medicines
The Biotherapeutics and Genetic Medicine (BGM) team at AbbVie is a critical discovery engine supporting our ambition to become the world’s leading biopharma company. We combine best-in-class internal technical platforms with the rapidly growing scientific ecosystem in China to deliver transformational large-molecule clinical development candidates to patients with unparalleled speed.
We are seeking a lead reporting to the Director of China Strategy BGM, who will build and enable a reliable external execution network in China. This role is the execution backbone of the China team, helping BGM teams effectively access and use CROs, CRDMOs, and other external resources for discovery and development support. The role requires practical partner management, rapid issue resolution, and hands-on coordination across internal stakeholders and external partners to ensure timely, high-quality delivery aligned with program priorities.
This individual will work closely with global BGM teams and partner functions across Discovery and Development, serving as a strong local presence and a trusted bridge between China-based providers and global program teams.
Responsibilities:
AbbVie is an equal opportunity employer and is committed to operating with integrity, driving innovation, transforming lives and serving our community. Equal Opportunity Employer/Veterans/Disabled.
US & Puerto Rico only - to learn more, visit https://www.abbvie.com/join-us/equal-employment-opportunity-employer.html
US & Puerto Rico applicants seeking a reasonable accommodation, click here to learn more:
https://www.abbvie.com/join-us/reasonable-accommodations.html
AbbVie is a global biopharmaceutical company that develops and sells medicines to treat serious health conditions. Its portfolio spans immunology, oncology, virology, neuroscience, and aesthetics, with products designed to modulate the immune system, target disease pathways, or support medical aesthetics. AbbVie compounds its products through a heavy emphasis on research and development, investing billions to build a steady pipeline of new therapies. Its medicines are brought to market by selling to healthcare providers, hospitals, and clinics, and in some cases directly to patients via prescriptions. The company differentiates itself through a wide, globally distributed product line, substantial R&D investment, and a commitment to sustainability and patient care, including science-based targets. AbbVie’s goal is to improve patient outcomes by delivering effective treatments for unmet medical needs while pursuing long-term, responsible growth across healthcare markets.
Explore more opportunities at AbbVie